PH25179A - Sustained release capsule - Google Patents

Sustained release capsule

Info

Publication number
PH25179A
PH25179A PH35400A PH35400A PH25179A PH 25179 A PH25179 A PH 25179A PH 35400 A PH35400 A PH 35400A PH 35400 A PH35400 A PH 35400A PH 25179 A PH25179 A PH 25179A
Authority
PH
Philippines
Prior art keywords
sustained release
release capsule
capsule
sustained
release
Prior art date
Application number
PH35400A
Other languages
English (en)
Inventor
Vikram Suresh Patel
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of PH25179A publication Critical patent/PH25179A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
PH35400A 1986-06-16 1987-06-15 Sustained release capsule PH25179A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/874,732 US4798725A (en) 1986-06-16 1986-06-16 Sustained release capsule

Publications (1)

Publication Number Publication Date
PH25179A true PH25179A (en) 1991-03-27

Family

ID=25364440

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35400A PH25179A (en) 1986-06-16 1987-06-15 Sustained release capsule

Country Status (13)

Country Link
US (1) US4798725A (ja)
EP (1) EP0250038B1 (ja)
JP (1) JPH0830007B2 (ja)
AT (1) AT398165B (ja)
AU (1) AU589866B2 (ja)
CA (1) CA1295247C (ja)
DE (1) DE3772269D1 (ja)
DK (1) DK306587A (ja)
IE (1) IE60586B1 (ja)
IL (1) IL82806A (ja)
NZ (1) NZ220696A (ja)
PH (1) PH25179A (ja)
ZA (1) ZA874315B (ja)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form
NL8701335A (nl) * 1986-06-21 1988-01-18 Sandoz Ag Orale farmaceutische preparaten.
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5178880A (en) * 1989-07-25 1993-01-12 Norwich Eaton Pharmaceuticals, Inc. Liquid suspensions of nitrofurantoin
US5332832A (en) * 1989-07-26 1994-07-26 Procter & Gamble Pharmaceuticals, Inc. Nitrofurantoin crystals
JPH03145418A (ja) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5484607A (en) * 1993-10-13 1996-01-16 Horacek; H. Joseph Extended release clonidine formulation
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
EP0862419B2 (en) 1995-11-09 2010-11-17 Microbiological Research Authority Microencapsulated dna for vaccination and gene therapy
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
IN186245B (ja) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US8524277B2 (en) * 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
US6406719B1 (en) 1998-05-13 2002-06-18 Microbiological Research Authority Encapsulation of bioactive agents
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
CN1195550C (zh) * 1998-12-28 2005-04-06 大正制药株式会社 外用剂
US6383515B2 (en) 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US6372252B1 (en) 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
ES2196948B1 (es) * 2001-03-29 2005-02-01 Easyblind, S.L. Persiana enrollable perfeccionada.
US20030012820A1 (en) * 2001-06-12 2003-01-16 Upadhyay Ajay Hasmukhlal Compressible guaifenesin compositions, method for making same and method for making compressed guaifenesin dosage forms therefrom
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
JP2005526079A (ja) * 2002-03-15 2005-09-02 サイプレス バイオサイエンス， インコーポレイテッド 内蔵痛症候群を処置するためのｎｅおよび５−ｈｔ再取り込み阻害剤
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
AU2003288588A1 (en) * 2002-12-16 2004-07-09 Ranbaxy Laboratories Limited An extended release pharmaceutical composition of phenytoin sodium
US20040228830A1 (en) * 2003-01-28 2004-11-18 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US20050152967A1 (en) * 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
BRPI0614949A2 (pt) * 2005-08-23 2011-04-26 Nissan Chemical Ind Ltd preparação de liberação sustentada
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
JP4926495B2 (ja) * 2006-02-22 2012-05-09 興和株式会社 イブプロフェン含有コーティング顆粒
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
AU2008261957A1 (en) * 2007-06-08 2008-12-18 Addrenex Pharmaceuticals, Inc. Extended release formulation and method of treating adrenergic dysregulation
US20100172991A1 (en) * 2007-06-08 2010-07-08 Henry Joseph Horacek Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
GB201506755D0 (en) 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
WO2017062997A1 (en) 2015-10-09 2017-04-13 Reckitt Benckiser Llc Pharmaceutical formulation
EP4285895A1 (en) 2022-06-03 2023-12-06 Adalvo Limited Nitrofurantoin oral dosage form

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL171628C (nl) * 1950-05-29 Inst Francais Du Petrole Inrichting voor het uitzenden van akoestische golven in een vloeibaar milieu.
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
US3427378A (en) * 1965-02-12 1969-02-11 American Cyanamid Co Sustained release encapsulated formula
GB1093286A (en) * 1965-02-15 1967-11-29 Biorex Laboratories Ltd Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet
GB1204580A (en) * 1968-10-05 1970-09-09 Aspro Nicholas Ltd Pharmaceutical dosage forms
US3634584A (en) * 1969-02-13 1972-01-11 American Home Prod Sustained action dosage form
US3851051A (en) * 1970-07-17 1974-11-26 Scherer R Corp Soft gelatin capsule containing high water content fill
US4152444A (en) * 1972-04-19 1979-05-01 Ciba-Geigy Corporation Pharmaceutical compound preparations with bactericidal action
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
FR2287216A1 (fr) * 1974-10-09 1976-05-07 Narcisse Guy Nouvelle forme galenique d'administration de medicaments et medicaments prepares sous cette nouvelle forme
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
FR2407720A1 (fr) * 1977-11-08 1979-06-01 Lipha Lyonnaise Indle Pharmace Preparations pharmaceutiques orales a activite therapeutique prolongee
US4247552A (en) * 1979-01-11 1981-01-27 Syntex (U.S.A.) Inc. Contraceptive compositions and methods employing 1-substituted imidazole derivatives
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system

Also Published As

Publication number Publication date
ZA874315B (en) 1988-08-31
IE60586B1 (en) 1994-07-27
ATA151587A (de) 1994-02-15
EP0250038A3 (en) 1989-01-18
EP0250038A2 (en) 1987-12-23
JPS63258407A (ja) 1988-10-25
IE871584L (en) 1987-12-16
AU7421287A (en) 1987-12-17
CA1295247C (en) 1992-02-04
DK306587A (da) 1987-12-17
US4798725A (en) 1989-01-17
DK306587D0 (da) 1987-06-16
NZ220696A (en) 1990-08-28
IL82806A0 (en) 1987-12-20
AT398165B (de) 1994-10-25
JPH0830007B2 (ja) 1996-03-27
IL82806A (en) 1990-11-29
EP0250038B1 (en) 1991-08-21
DE3772269D1 (de) 1991-09-26
AU589866B2 (en) 1989-10-19

Similar Documents

Publication Publication Date Title
ZA874315B (en) Sustained release capsule
AU108030S (en) Capsule
EP0187703A3 (en) Sustained release preparation
ZA868039B (en) Sustained release tablets
ZA88941B (en) Sustained release dosage forms
ZA851891B (en) Sustained release pharmaceutical capsules
ZA886686B (en) Capsules
GB8705516D0 (en) Capsule holder
GB2176999B (en) Sustained release medicament
JPS6490279A (en) Silicone release
GB2195893B (en) Sustained release pharmaceutical compositions
GB2188915B (en) Tablets
GB8608715D0 (en) Capsules
EP0254274A3 (en) Release agent
GB8629761D0 (en) Capsules
GB8708674D0 (en) Shell
ZA882773B (en) Microencapsulation
GB8726139D0 (en) Communication capsule
CA55865S (en) Capsule
CA60942S (en) Capsule
SG27194G (en) Sustained release etodaloc
GB8714278D0 (en) Capsules
IE862306L (en) Controlled release tablet
IE850698L (en) Sustained release pharmaceutical capsule
GB8607041D0 (en) Capsule assembly